Peply

Compounds

Compound Reference

Published clinical data, titration protocols, and regulatory status for referenced peptides and injectables.

21 compounds

Semaglutide

FDA Approved

Ozempic, Wegovy

GLP-1 Agonist

Mimics GLP-1 to enhance insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite via hypothalamic signaling.

0.25-2.4 mg|Once weekly

View Details →

Tirzepatide

FDA Approved

Mounjaro, Zepbound

Dual Agonist

Activates both GIP and GLP-1 receptors, enhancing insulin secretion, suppressing glucagon, slowing gastric emptying, and reducing appetite through complementary incretin pathways.

2.5-15 mg|Once weekly

View Details →

Retatrutide

Investigational

LY3437943

Triple Agonist

Activates three receptors simultaneously: GIP (enhances insulin), GLP-1 (suppresses appetite, slows gastric emptying), and glucagon (increases energy expenditure and hepatic fat oxidation). The glucagon component distinguishes it from dual agonists.

2-12 mg|Once weekly

View Details →

Tesamorelin

FDA Approved

Egrifta, Egrifta SV

Growth Hormone

Synthetic analog of human growth hormone-releasing factor (GRF 1-44). Binds to GRF receptors in the pituitary to stimulate endogenous growth hormone synthesis and release, preserving the pulsatile secretion pattern.

2 mg|Once daily

View Details →

BPC-157

Cat 2 → Pending Cat 1

Body Protection Compound-157

Growth & Recovery

Gastric pentadecapeptide. Promotes angiogenesis, tendon/ligament healing, and nitric oxide signaling. Modulates growth factor expression.

200-800 mcg|1-2x daily

View Details →

TB-500

Cat 2 → Pending Cat 1

Thymosin Beta-4, TB4

Growth & Recovery

Synthetic fragment of Thymosin Beta-4. Upregulates actin, promotes cell migration and differentiation, reduces inflammation, and supports tissue repair.

2-5 mg|2x/week (loading), 1x/week (maintenance)

View Details →

GHK-Cu

Cat 2 → Pending Cat 1

Copper Peptide GHK, Glycyl-L-histidyl-L-lysine

Growth & Recovery

Naturally occurring copper-binding tripeptide. Stimulates collagen synthesis, promotes wound healing, has anti-inflammatory and antioxidant properties. Activates tissue remodeling genes.

1-3 mg|Once daily

View Details →

AOD-9604

Cat 2 → Pending Cat 1

Anti-Obesity Drug 9604, hGH Fragment 176-191

Growth & Recovery

Modified fragment of human growth hormone (amino acids 176-191). Stimulates lipolysis and inhibits lipogenesis without affecting IGF-1 levels or insulin sensitivity.

250-500 mcg|Once daily

View Details →

Thymosin Alpha-1

Cat 2 → Pending Cat 1

Ta1, Zadaxin

Growth & Recovery

Naturally occurring thymic peptide. Enhances T-cell maturation and function, activates dendritic cells, augments antibody responses. Modulates cytokine production.

1.6-3.2 mg|2x/week

View Details →

Ipamorelin

Cat 2 → Pending Cat 1

GH Secretagogue

Selective growth hormone secretagogue peptide. Binds ghrelin/GHS receptors in the pituitary to stimulate GH release without significantly affecting cortisol, prolactin, or ACTH levels.

100-300 mcg|2-3x daily

View Details →

CJC-1295 (no DAC) / Modified GRF 1-29

Cat 2 → Pending Cat 1

Modified GRF 1-29, Mod GRF 1-29

GH Secretagogue

Synthetic analog of growth hormone-releasing hormone (GHRH). Stimulates pulsatile GH release from the pituitary. The "no DAC" variant has a shorter duration and preserves natural GH pulsatility.

100-300 mcg|2-3x daily

View Details →

CJC-1295 (with DAC)

Cat 2 → Pending Cat 1

CJC-1295 DAC, Drug Affinity Complex CJC-1295

GH Secretagogue

GHRH analog with a Drug Affinity Complex (DAC) that extends its half-life by binding to albumin. Produces sustained, elevated GH and IGF-1 levels rather than pulsatile release.

1-2 mg|Once weekly

View Details →

Semax

Cat 2 → Pending Cat 1

ACTH 4-10 analog

Neuropeptide

Synthetic analog of ACTH (4-10) fragment. Enhances BDNF expression, modulates dopaminergic and serotonergic systems, provides neuroprotective effects. Does not affect adrenal cortex function despite ACTH origin.

200-600 mcg|Once daily (intranasal or SC)

View Details →

Selank

Cat 2 → Pending Cat 1

TP-7

Neuropeptide

Synthetic analog of the immunomodulatory peptide tuftsin with a stabilizing Pro-Gly-Pro sequence. Modulates GABA-A receptor expression, enhances enkephalin levels, and provides anxiolytic effects without sedation or dependence.

200-400 mcg|Once daily (intranasal or SC)

View Details →

DSIP (Delta Sleep-Inducing Peptide / Emideltide)

Cat 2 → Pending Cat 1

Delta Sleep-Inducing Peptide, Emideltide

Neuropeptide

Nonapeptide that modulates sleep architecture. Acts on multiple targets including GABA-A receptors, serotonergic pathways, and cortisol regulation. Promotes delta-wave sleep onset without causing sedation.

100-300 mcg|Once daily (before sleep)

View Details →

Epitalon (Epithalon)

Cat 2 → Pending Cat 1

Epithalon, Epithalone

Longevity & Immune

Synthetic tetrapeptide (Ala-Glu-Asp-Gly) analog of epithalamin. Activates telomerase, the enzyme responsible for maintaining telomere length. May promote pineal gland function and melatonin production.

5-10 mg|Daily in 10-day cycles

View Details →

MOTS-C (Mitochondrial ORF of the 12S rRNA Type-C)

Cat 2 → Pending Cat 1

Mitochondrial-Derived Peptide MOTS-c

Longevity & Immune

Mitochondrial-derived peptide encoded within the 12S rRNA gene. Activates AMPK pathway, enhances glucose uptake, improves insulin sensitivity, and regulates cellular metabolism. Functions as a mitochondrial signaling molecule.

5-10 mg|3-5x/week

View Details →

KPV (Lys-Pro-Val)

Cat 2 → Pending Cat 1

Lysine-Proline-Valine, Alpha-MSH Fragment

Longevity & Immune

C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). Potent anti-inflammatory activity via NF-kB inhibition and PGE2 reduction. Modulates gut inflammation and mucosal immune response.

200-500 mcg|Once daily

View Details →

Kisspeptin-10

Cat 2 → Pending Cat 1

KP-10, Metastin 45-54

Longevity & Immune

Decapeptide fragment of kisspeptin that activates KISS1R (GPR54) in hypothalamic GnRH neurons. Potently stimulates LH and FSH secretion, serving as a key regulator of the reproductive hormone axis.

75-750 mcg|Single dose (weight-based: 1-10 mcg/kg)

View Details →

5-Amino-1MQ

Category 1

5-amino-1-methylquinolinium

Metabolic

Selectively inhibits nicotinamide N-methyltransferase (NNMT), preserving nicotinamide for NAD+ synthesis, activating SIRT1 pathways, promoting mitochondrial biogenesis, and enhancing fat oxidation. Note: This is a small molecule, not a peptide.

150-500 mcg|Once daily SC (oral: 50-150 mg/day)

View Details →

IGF-1 LR3

Category 1

Long R3 IGF-1, Long Arginine 3-IGF-1

Growth & Recovery

Long-acting analog of IGF-1 with an extended N-terminal peptide (arginine substitution at position 3 + 13-amino-acid extension). Reduced binding to IGF binding proteins (IGFBPs) results in longer half-life and greater bioavailability. Promotes muscle hyperplasia, protein synthesis, and glucose uptake in muscle tissue.

20-100 mcg|Once daily (often post-workout)

View Details →